Skip to content

Electronic Capturing of Activities During REhabilitation for Upper Limb After Stroke

Electronic Capturing of Activities During REhabilitation for Upper Limb After Stroke

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06527261
Acronym
eCARE4Stroke
Enrollment
146
Registered
2024-07-30
Start date
2024-07-31
Completion date
2026-12-31
Last updated
2024-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Usual care, Upper extremity, Dose, Rehabilitation

Brief summary

This is a prospective cohort study to determine the feasibility of accurate, complete, and timely real-time electronic capturing of upper limb motor intervention sessions during usual care. In clinical trials accurate reporting of usual care for people with stroke is scarce, thus understanding the control group compared to the experimental group is poor. The unit of measure in this study is therapy sessions, where a clinician is providing usual care to a patient. The observed sessions will occur in two Austin Health settings: Acute at Austin Hospital; subacute, across Royal Talbot Rehabilitation Centre or the Heidelberg Repatriation Hospital. For each session, patient characteristics, dose and content of upper limb interventions will be electronically captured in REDCap. Additionally, the sessions will be video recorded to allow a second rater to assess feasibility. The secondary aim is to determine if there is an association between the dose and content of upper limb intervention sessions and the contextual factors of stroke patients. Two participant groups will be recruited: Stroke patients and Clinicians (Occupational Therapists and Allied Health Assistants).

Detailed description

This is a prospective observational cohort study to determine the feasibility of accurate, complete, and timely real-time electronic capturing of upper limb motor intervention sessions during usual care. In clinical trials accurate reporting of usual care for people with stroke is scarce, thus understanding the control group compared to the experimental group is poor. The unit of measure is the therapy sessions, where a clinician is providing usual care to a patient. The observed sessions will occur across two Austin Health settings. Setting A: Acute at Austin Hospital, and Setting B: Subacute at Royal Talbot Rehabilitation Centre or the Heidelberg Repatriation Hospital. For each session, patient characteristics, the multiple dimensions of dose, and the content of usual care motor upper limb interventions will be electronically captured in REDCap. The observed sessions will be video recorded and a second rater will review the session for dose data accuracy. Secondary to determining feasibility, the dose and content data from observed sessions will be analysed to investigate the association of context factors such as setting and upper limb impairment severity. As such, this study aims to answer the following research questions: * Is it feasible for clinicians to electronically capture accurate, complete, and timely upper limb motor intervention session dose during usual care of stroke patients? * Is there an association between dose and content of upper limb intervention sessions and the contextual factors of stroke patients?

Interventions

OTHERReal-time electronic data input into REDCap

During usual care sessions, clinicians will real-time capture information about the intervention session into REDCap. This information is related to the multi-dimensional dose articulation framework e.g., content of the session and difficulty of the task, session length, episode length, and number of repetitions. The usual care motor upper limb intervention the patient receives is determined by the clinician providing the care. The therapy may include but is not limited to strength training, task specific retraining, constraint induced movement therapy, mirror box, and electrical stimulation.

Sponsors

University of Melbourne
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Group 1: Stroke patients Inclusion Criteria: * Adults (≥18 years) with a new, first or consecutive stroke, confirmed on CT or MRI. * Motor upper limb impairment defined by a Shoulder Abduction and Finger Extension (SAFE) score of 0 through 9. * Able to consent for themselves. * Likely to receive at least one upper limb intervention session as determined by the treating clinical team.

Exclusion criteria

* Existing co-morbidities that limit upper limb function and usual care treatment provided as determined by the treating clinical team e.g., neural or orthopeadic * Receiving palliative care or have a limited life expectancy * Deemed unable or unnecessary to participate in upper limb intervention by the treating clinical team * Treating Occupational Therapist and local allied health assistant declined to participate in the research preventing recording of usual care data * Unable to follow basic instructions in English Group 2: Clinicians Inclusion criteria * Occupational therapist or allied health assistant working with the stroke population in an acute or subacute settings within Austin Health. * At least four months of clinical experience

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of real-time electronic data input of usual care session doseEach feasibility session will take up to one hour.A single binary composite primary outcome, where feasibility is defined by 90% of sessions achieving ALL of: 1. Binary outcome of Accuracy: ≤10% difference in dose between electronic data and second-rater data from a video recording of the session as defined by the decision algorithm. 2. Binary outcome of Completeness: ≥90% of the electronic data completed by clinicians as defined by the decision algorithm. 3. Binary outcome of Timeliness: ≤10% of session time is spent completing the electronic record or rated non-burdensome by the clinician as defined by the decision algorithm.

Countries

Australia

Contacts

Primary ContactKate Hayward, PhD
kate.hayward@unimelb.edu.au+61 03 9035 5511
Backup ContactSarah P Newton, BOccTh(Hons)
spnewton@student.unimelb.edu.au+61 03 94965105

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026